• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非编码 RNA 在肝细胞癌中的新兴作用和潜在临床应用。

Emerging roles and potential clinical applications of noncoding RNAs in hepatocellular carcinoma.

机构信息

State Key Laboratory of Proteomics, National Center for Protein Sciences at Beijing, Beijing Institute of Radiation Medicine, Beijing, China.

Key Laboratory of Risk Assessment and Control for Environment & Food Safety, Tianjin Institute of Environmental & Operational Medicine, Tianjin City, China.

出版信息

Semin Cancer Biol. 2021 Oct;75:136-152. doi: 10.1016/j.semcancer.2020.09.003. Epub 2020 Sep 12.

DOI:10.1016/j.semcancer.2020.09.003
PMID:32931952
Abstract

Hepatocellular carcinoma(HCC) is one of the most common forms of cancer, and accounts for a high proportion of cancer-associated deaths. Growing evidences have demonstrated that non- protein-coding regions of the genome could give rise to transcripts, termed noncoding RNA (ncRNA), that form novel functional layers of the cellular activity. ncRNAs are implicated in different molecular mechanisms and functions at transcriptional, translational and post-translational levels. An increasing number of studies have demonstrated a complex array of molecular and cellular functions of ncRNAs in different stages of the HCC tumorigenesis, either in an oncogenic or tumor-suppressive manner. As a result, several pre-clinical studies have highlighted the great potentials of ncRNAs as novel biomarkers for cancer diagnosis or therapeutics in targeting HCC progression. In this review, we briefly described the characteristics of several representative ncRNAs and summarized the latest findings of their roles and mechanisms in the development of HCC, in order to better understand the cancer biology and their potential clinical applications in this malignancy.

摘要

肝细胞癌(HCC)是最常见的癌症类型之一,占癌症相关死亡的很大比例。越来越多的证据表明,基因组的非蛋白编码区域可以产生转录本,称为非编码 RNA(ncRNA),它们构成细胞活动的新功能层。ncRNA 参与转录、翻译和翻译后水平的不同分子机制和功能。越来越多的研究表明,ncRNA 在 HCC 肿瘤发生的不同阶段具有复杂的分子和细胞功能,无论是致癌还是肿瘤抑制方式。因此,一些临床前研究强调了 ncRNA 作为癌症诊断或治疗 HCC 进展的新型生物标志物的巨大潜力。在这篇综述中,我们简要描述了几种代表性 ncRNA 的特征,并总结了它们在 HCC 发展中的作用和机制的最新发现,以便更好地了解癌症生物学及其在这种恶性肿瘤中的潜在临床应用。

相似文献

1
Emerging roles and potential clinical applications of noncoding RNAs in hepatocellular carcinoma.非编码 RNA 在肝细胞癌中的新兴作用和潜在临床应用。
Semin Cancer Biol. 2021 Oct;75:136-152. doi: 10.1016/j.semcancer.2020.09.003. Epub 2020 Sep 12.
2
The role of long noncoding RNAs in hepatocellular carcinoma.长链非编码 RNA 在肝细胞癌中的作用。
Mol Cancer. 2020 Apr 15;19(1):77. doi: 10.1186/s12943-020-01188-4.
3
Non-coding RNA in drug resistance of hepatocellular carcinoma.非编码 RNA 在肝癌耐药中的作用。
Biosci Rep. 2018 Oct 9;38(5). doi: 10.1042/BSR20180915. Print 2018 Oct 31.
4
Long non-coding RNAs HERH-1 and HERH-4 facilitate cyclin A2 expression and accelerate cell cycle progression in advanced hepatocellular carcinoma.长非编码 RNA HERH-1 和 HERH-4 促进细胞周期蛋白 A2 的表达并加速晚期肝细胞癌的细胞周期进程。
BMC Cancer. 2021 Aug 26;21(1):957. doi: 10.1186/s12885-021-08714-7.
5
Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.长链非编码 RNA UPK1A-AS1 提示肝细胞癌预后不良,并通过与 EZH2 相互作用促进细胞增殖。
J Exp Clin Cancer Res. 2020 Oct 29;39(1):229. doi: 10.1186/s13046-020-01748-y.
6
Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.长链非编码 RNA AWPPH 通过 YBX1 促进肝细胞癌进展,并作为一种预后生物标志物。
Biochim Biophys Acta Mol Basis Dis. 2017 Jul;1863(7):1805-1816. doi: 10.1016/j.bbadis.2017.04.014. Epub 2017 Apr 18.
7
Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.长链非编码 RNA ZFPM2-AS1 通过调控 miR-139/GDF10 促进肝癌细胞侵袭。
J Exp Clin Cancer Res. 2020 Aug 14;39(1):159. doi: 10.1186/s13046-020-01664-1.
8
The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.微小 RNA 和长链非编码 RNA 在肝癌耐药中的新兴作用。
Mol Cancer. 2019 Oct 25;18(1):147. doi: 10.1186/s12943-019-1086-z.
9
RNA sequencing reveals the long noncoding RNA and mRNA profiles and identifies long non-coding RNA TSPAN12 as a potential microvascular invasion-related biomarker in hepatocellular carcinoma.RNA 测序揭示长非编码 RNA 和 mRNA 谱,并鉴定长非编码 RNA TSPAN12 为肝癌微血管侵犯相关的潜在生物标志物。
Biomed Pharmacother. 2020 Jun;126:110111. doi: 10.1016/j.biopha.2020.110111. Epub 2020 Mar 26.
10
The long noncoding RNA links the microRNA miR-215 to oncogene CRKL-mediated signaling in hepatocellular carcinoma.长链非编码RNA将微小RNA miR-215与肝细胞癌中癌基因CRKL介导的信号传导联系起来。
J Biol Chem. 2017 Oct 27;292(43):17939-17949. doi: 10.1074/jbc.M116.773978. Epub 2017 Sep 8.

引用本文的文献

1
The LncRNA lnc-POTEM-4:14 promotes HCC progression by interacting with FOXK1.长链非编码RNA lnc-POTEM-4:14通过与FOXK1相互作用促进肝癌进展。
Sci Rep. 2025 Mar 5;15(1):7672. doi: 10.1038/s41598-025-92614-4.
2
Cytoglobin augments ferroptosis through autophagic degradation of ferritin in colorectal cancer cells.细胞珠蛋白通过自噬降解结直肠癌细胞中的铁蛋白增强铁死亡。
Mol Cell Biochem. 2025 May;480(5):2881-2892. doi: 10.1007/s11010-024-05148-0. Epub 2024 Nov 6.
3
The AC010247.2/miR-125b-5p axis triggers the malignant progression of acute myelocytic leukemia by IL-6R.
AC010247.2/miR-125b-5p轴通过白细胞介素-6受体触发急性髓细胞白血病的恶性进展。
Heliyon. 2024 Sep 10;10(18):e37715. doi: 10.1016/j.heliyon.2024.e37715. eCollection 2024 Sep 30.
4
RP11-495P10.1 promotes HCC cell proliferation by regulating reprogramming of glucose metabolism and acetylation of the NR4A3 promoter via the PDK1/PDH axis.RP11-495P10.1 通过 PDK1/PDH 轴调节葡萄糖代谢重编程和 NR4A3 启动子乙酰化促进 HCC 细胞增殖。
Acta Biochim Biophys Sin (Shanghai). 2024 Jan 25;56(1):44-53. doi: 10.3724/abbs.2023242.
5
Exosome-transported circHDAC1_004 Promotes Proliferation, Migration, and Angiogenesis of Hepatocellular Carcinoma by the miR-361-3p/NACC1 Axis.外泌体转运的circHDAC1_004通过miR-361-3p/NACC1轴促进肝细胞癌的增殖、迁移和血管生成。
J Clin Transl Hepatol. 2023 Oct 28;11(5):1079-1093. doi: 10.14218/JCTH.2022.00097. Epub 2023 Mar 22.
6
Identification of an immune-related 6-lncRNA panel with a good performance for prognostic prediction in hepatocellular carcinoma by integrated bioinformatics analysis.基于整合生物信息学分析鉴定出一个具有良好性能的免疫相关 6 个长链非编码 RNA 标志物用于肝癌的预后预测。
Medicine (Baltimore). 2023 Jul 21;102(29):e33990. doi: 10.1097/MD.0000000000033990.
7
Prediction of 3-year recurrence rate of hepatocellular carcinoma after resection based on contrast-enhanced CT: a single-centre study.基于增强 CT 预测肝细胞癌切除术后 3 年复发率:一项单中心研究。
Br J Radiol. 2023 Apr 1;96(1145):20220702. doi: 10.1259/bjr.20220702. Epub 2023 Feb 14.
8
Modification Patterns of DNA Methylation-Related lncRNAs Regulating Genomic Instability for Improving the Clinical Outcomes and Tumour Microenvironment Characterisation of Lower-Grade Gliomas.DNA甲基化相关长链非编码RNA调控基因组不稳定以改善低级别胶质瘤临床结局及肿瘤微环境特征的修饰模式
Front Mol Biosci. 2022 Mar 10;9:844973. doi: 10.3389/fmolb.2022.844973. eCollection 2022.
9
Prognostic role of multiparameter MRI and radiomics in progression of advanced unresectable hepatocellular carcinoma following combined transcatheter arterial chemoembolization and lenvatinib therapy.多参数 MRI 和放射组学在经导管动脉化疗栓塞联合仑伐替尼治疗后进展期不可切除肝细胞癌进展中的预后价值。
BMC Gastroenterol. 2022 Mar 8;22(1):108. doi: 10.1186/s12876-022-02129-9.
10
CDKN2A is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.CDKN2A 是肝细胞癌的预后生物标志物,并与免疫浸润相关。
Biosci Rep. 2021 Oct 29;41(10). doi: 10.1042/BSR20211103.